Drug – bio-affecting and body treating compositions – Antigen – epitope – or other immunospecific immunoeffector – Recombinant virus encoding one or more heterologous proteins...
Reexamination Certificate
2006-10-31
2006-10-31
Mosher, Mary E. (Department: 1648)
Drug, bio-affecting and body treating compositions
Antigen, epitope, or other immunospecific immunoeffector
Recombinant virus encoding one or more heterologous proteins...
C424S093200, C514S04400A
Reexamination Certificate
active
07128916
ABSTRACT:
The present invention relates to vaccines comprising a bacteriophage which has been engineered to express an immunogenic protein/peptide and wherein the surface of the bacteriophage has not been modified to contain proteins/peptides designed to target the phage to receptors on the surface of specific cell types.
REFERENCES:
patent: 5736388 (1998-04-01), Chada et al.
patent: 6054312 (2000-04-01), Larocca et al.
patent: 2003/0113293 (2003-06-01), Bermudes et al.
patent: WO 9805344 (1998-02-01), None
patent: WO 9910014 (1999-03-01), None
patent: WO99/055720 (1999-11-01), None
Horst et al PNAS 72:3531-3535, 1975.
Bastien et al (Virology 234:118-122, 1997).
Douglas, R.G. Transactions of the American Clinical and Climatological Association 109: 185-198, 1998.
Aujame et al. “Experimental Design Optimization of Filamentous Phage Transfection into Mammalian Cells by Cationic Lipids”,Biotechniques28:1202-1213 (2000).
Horst et al. “Gene transfer to human cells: Transducing phage λplac gene expression in GMI-gangliosidosis fibrosis”,Proc. Natl. Acad. Sci. 72:3531-3535 (1975).
Okayama et al. “Bacteriophage Lambda Vector for Transducing a cDNA Clone Library into Mammalian Cells”,Molec. and Cell. Biol. 5:1136-1142 (1985).
Srivatsan et al. “Plasmid, phage, and genomic DNA-mediated transfer and expression of prokaryotic and eukaryotic genes in cultured human cells”,Cytogenet. Cell Genet. 38:227-234 (1984).
Bastien, N., et al. “Protective Immune Responses Induced by the Immunization of Mice with a Recombinant Bacteriophage Displaying a Epitope of the Human Respiratory Syncytial Virus”Virology234:118-122 (1997).
De Berardinis, P., et al. “Phage Display of Peptide Epitopes From HIV-1 Elicits Strong Cytolytic Response”Nature Biotechnology18:2000.
Gaubin, M., et al. “Processing of Filamentous Bacteriophage Virions in Antigen-Presenting Cells Targets Both HLA Class I and Class II Peptide Loading Compartments”DNA and Cell Biology22(1):11-18 (2003).
International Search Report corresponding to PCT/GB02/01413. Mailed Jun. 13, 2003.
Ishiura, M., et al. “Phage Particle-Mediated Gene Transfer to Cultured Mammalian Cells”Molecular and Cellular Biology2(6):607-616 (Jun. 1982).
Monahan, S.J., et al. “Viral Vectors for Gene Transfer into Antigen Presenting Cells”Molecular Therapeutics1(5):558-564 (1999).
Vincent, J.A., et al. “An In Vitro, Complement-Dependent Model of Particle Transfer From Erythrocytes to Macrophages”Immunopharmacology49(1-2):90 (Aug. 2000).
De Berardinis, P., et al. “Phage Display of Peptide Epitopes From HIV-1 Elicits Strong Cytolytic Response”Nature Biotechnology, 18:873-876 (2000).
Moredun Research Institute
Mosher Mary E.
Myers Bigel & Sibley Sajovec, PA
LandOfFree
Bacteriophage-mediated immunisation does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Bacteriophage-mediated immunisation, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Bacteriophage-mediated immunisation will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-3689345